INTRODUCTION
Improved screening, early diagnosis, treatment, and an aging population, have led to an increase in the number of people living with or surviving cancer, with prevalence and survival estimates projected to continue to increase dramatically in future decades.
1,2 Lifetime probability rates for diagnosis of an invasive cancer are up to 45 % for men and 38 % for women, 3 and, for many cancer types and stages, five-year survival rates have increased for both adult and childhood cancers, 3, 4 resulting in increased pressure being placed on health-care systems at all stages of the cancer care continuum.
In addition to the acute effects of primary disease and treatment, health professionals must also meet the needs of survivors who remain at risk of relapse, development of a second cancer, 5, 6 and long-term morbidity related to the physical and psychosocial late effects of their disease and/or its treatment. 7, 8 Providing care for childhood cancer survivors is a particular challenge, as approximately two-thirds will experience chronic late effects 9 during survivorship periods, which will, on average, span six decades. 10, 11 Additionally, health professionals must also meet the needs of aging cancer survivors who are at increased risk of comorbid disease and increased health-care service utilisation. 12, 13 Oncologists located at tertiary hospitals have traditionally provided the majority of cancer treatment and routine followup for patients with cancer. [14] [15] [16] However, workforce shortages in oncology, combined with an exponentially increasing number of cancer survivors, reduced the sustainability of a specialist-based model of care. 17 Some researchers predict that there will be insufficient oncologists to meet the needs of cancer patients and survivors in the future, with demand predicted to rise 48 % between 2005 and 2020. 18 Oncologist-led follow-up is expensive, with other models of care, such as primary care based management, demonstrating greater cost-effectiveness than hospital-based alternatives, with minimal variation in key outcomes documented for breast cancer patients. 14, 15, 19, 20 Oncologist-led care presents additional challenges, including difficulties in maintaining patient-oncologist contact as survivors transition through life-phases (for example, childhood cancer survivors, who may have more than six decades of life expectancy ahead, may move away from home and their treating hospital to pursue tertiary study, careers and relationships) or should survivors reside significant distances from the treating hospital. [21] [22] [23] In response to these barriers to oncologist-led follow-up, it has been suggested that primary care physicians (PCPs) may be suitable to assume a greater role in cancer care. As primary care providers, PCPs foster long-term relationships with patients and are well placed within the community to holistically manage health-care, integrating cancer care into preexisting and ongoing primary care. 15, 24 In terms of health outcomes, a PCP-based follow-up system may be a safe alternative to oncologist care, 19, 25 and in some instances patients are more satisfied with follow-up. 26 PCP follow-up may also allow better continuity of care, improved individual patient support, more proactive care, and improvements in teamwork between disciplines. 27 A recent rapid review suggests that while the efficacy of PCP involvement and provision of such care is restricted by limitations in knowledge, and the attitudes/beliefs of both patients and physicians, increasing PCP involvement in cancer care has promise given that it is both structured and individualised, potentially utilising clear guidelines and electronic resources. 28, 29 However, it is unclear whether PCPs are willing and able to fulfil this role with little to no specialist training in cancer care. 30 Also unknown is whether the PCP workforce may be limited and under similar strain to hospital-based alternatives in the future. 31 Survivors of childhood cancers present an additional challenge, as PCPs encounter fewer cases and have limited paediatric oncology knowledge, 32 and there remains a dearth of evidence exploring the optimal model follow-up care for this population. 33 A clearer understanding of PCPs' preferences for involvement in cancer care is needed to explore the feasibility of a primary care based follow-up system. The significant amount of research that has already investigated PCPs' preferences represents an opportunity to make informed changes within health-care systems and potentially increase the quality of life and survival of cancer patients. 34 It is timely then that these findings be synthesised. This review therefore aimed to summarise the available evidence on PCPs' perspectives of their role within cancer care.
METHOD Data Sources and Searches
We conducted a systematic review to investigate primary care physicians' (PCPs') views of their role in providing care for cancer patients and survivors. The inclusion criteria were studies that assessed (1) PCPs' perspectives; (2) related to the provision of patient care; in (3) cancer. Both qualitative and quantitative studies were included. This review was conducted in accordance with the PRISMA reporting guidelines. 35 The following electronic bibliographic databases were searched: MEDLINE; MEDLINE In-Process & NonIndexed Citations; EMBASE; PsycINFO and CINAHL. The same key words were used in all databases in addition to similar MeSH headings. Similar search terms were combined using 'OR' to create search themes (e.g. neoplasm OR oncol$ OR cancer), and these themes were then combined using 'AND' [e.g. (neoplasm OR oncol$ OR cancer) AND (general practitioner OR family physician OR primary care physician)]. The search algorithm is detailed in Table 1 . Searches were limited to human studies published in English from 1993-2015 and excluded studies focused on cancer diagnosis only.
Study Selection and Data Extraction
The search captured 924 abstracts, 163 of which were duplicates and, thus, removed. To augment the electronic search, we also conducted manual searches of reference lists, yielding an additional nine abstracts. The resulting 770 abstracts were hand screened by the lead author to establish appropriateness for inclusion in the review and also by a trained research assistant to ensure reliability. Studies were excluded for the following reasons (ordered by most common reason for exclusion): (1) not PCPs' perspective; (2) not related to PCPs' involvement in cancer care; (3) not cancer-specific; (4) not Figure 1 .
Each captured article was critically appraised according to pre-determined criteria, adapted from international recommendations. 36, 37 Two independent reviewers extracted data from the included studies and combined the data into themes to reveal trends within the data. They also assessed study quality and strength of evidence. 
RESULTS

Study Selection, Characteristics and Results
The review captured 35 relevant articles representing the views of 10,941 primary care physicians (PCPs). Table 2 summarises the findings of included studies. Articles originated from 11 countries, including: United States (10), Canada (9), the Netherlands (4), Australia (3), Norway (3), France (2), United Kingdom (2), Germany (1), Italy (1), Ireland (1) and Israel (1) . Two articles focused on childhood cancer survivors and the remainder were adult-focused.
Quality Assessment
All included studies had clearly described aims, methodology and used appropriate sampling procedures. However, many studies did not utilise standardised or validated outcome measures, limiting comparison across studies. Response rates were generally poor, varying between 5 % and 100 %, with a median of 53.5 %. Fourteen studies failed to report a response rate. In some instances, studies reported results without exploring contextual elements, such as country-specific health care systems.
PCP Preferences for Models of Care
The majority of PCPs desired involvement in all aspects of cancer care, 39, 43 and approximately 55 % of PCPs reported broad involvement. 46 PCP involvement typically varied across the cancer trajectory with approximately 85-90 % of PCPs involved in diagnosis, 39, 45, 48 45 % involved during treatment and 70-80 % during the survivorship phase. 39 The majority of PCPs (approximately 55-65 %) believed that they should have been involved at an earlier stage of aftercare. 44, 50, 68 Similarly, some PCPs expressed frustration at their lack of involvement during treatment, 70 though others agreed that treatment was best administered in a hospital setting and need for their input was minimal. 38, 43 Overall, PCPs (approximately 95 %) were consistent in their preference for a more active role in providing comprehensive patient care. 62 PCPs desired involvement in areas including pain management, 41 Approximately 50 % of PCPs participating in the reviewed studies were involved in a shared model of care. 39 One study reported that PCPs were prepared to accept exclusive responsibility for routine follow-up approximately two to four years from the completion of active treatment 44 ; however, another reported that less than half of participants were willing to provide such care five years post treatment. 64 The perceived benefits of a shared care model included greater psychosocial support and economic cost savings for patients and the healthcare system. 53 PCPs questioned the practicality and efficiency of a standardised proactive model of care, showing preference for a demand-driven approach. 47 50, 63 ; however, about half felt unprepared to manage longterm side-effects 40 or conduct surveillance for recurrence. 60 In general, high levels of confidence were reported for tasks such as pain management, 55 conveying bad news 71 and psychological support. 50, 63, 64, 67 However, lower levels of training or knowledge were reported for areas such as surveillance testing, 60 active treatment or surgery 38, 54 and advising on complementary therapies, 61 leading to a reluctance to fulfil such roles.
Communication with Oncologists
PCPs strongly endorsed improved communication with oncologists so that they could provide improved care for their patients. 56, 58, 60, 62, 69, 70 PCPs reported that they rarely or inconsistently received sufficient correspondence from oncologists. 43, 48, 52, 58, 60, 67 Though oncologists' letters contained details on investigation and examination findings, items such as treatment/management plans, future management and expectations, goals and procedures of follow-up, and psychosocial concerns were less commonly mentioned. 56, 62 In one study, approximately half of PCPs reported never having received a treatment summary. 57 PCPs strongly recommended improved communication with oncologists so that they could effectively treat cancerrelated issues concurrently with oncologist-led treatment of the primary malignancy. 56, 58, 60, 62, 69, 70 PCPs suggested improving post-treatment follow-up through a shared data management system, 53 such as the broad integration of electronic medical records and standard communication procedures between PCPs and specialists. 65, 70 Provision of patient-specific standard guidelines notated by oncologists 40, 44, 48, 59, 69 or meetings aimed at sharing information and defining roles 38 were also endorsed. Electronic communication and mail were valued, 40, 58, 65, 69 but not to the exclusion of personal interaction with specialists, which was preferred.
56,58,65
Information Needs
PCPs commonly reported that primary-care guidelines were not well defined or consistent for cancer survivors, 62, 70 and that there was a need for timely, detailed and regular transfer of information. 52 In terms of information preferences, 85-99 % of PCPs would have liked to have received additional information from oncologists regarding cancer treatments, 40, 56, 57 the referring PCP's role, 56 findings of investigations and likely prognosis, 56 the oncologist's follow-up plan, 56, 57 clinical practice guidelines for survivorship care, 40 and potential short and long term sideeffects, including suggested management.
56,57,69 PCPs suggested 70 % of PCPs reported confidence in conveying bad news; 5 % felt they had poor or no skills. 74 % thought discussion the of emotional impact should occur with patients, 11 % would delegate to a social worker and 6 % would avoid unless expressed by the patient. Barriers to initiating such discussions included: time constraints (38 %) and lack of skill (13 %).
(continued on next page) Highly rated reasons for follow-up included: checking for reoccurrence (94 %), reassuring patients (87 %), providing information on late effects (83 %) and to learn more about late effects (83 %). PCPs considered the advantages of primary-cared based follow-up to include: pre-existing relationships with patients (82 %), accessibility (69 %) and lower costs (66 %). PCPs felt they are appropriately located to provide supportive follow-up and may help limit feelings of abandonment that follow discharge. Major disadvantages of PCP involvement included: insufficient budgets (79 %), limited time (77 %), and lack of appropriate expertise (75 %). Grunfeld 50 United Kingdom 180 82 % Qualitative study of PCPs of patients enrolled in a randomised trial comparing community and hospital follow-up for breast cancer.
18 % of PCPs agreed that hospital followup provides important psychosocial support. 69 % of PCPs considered they had the necessary skills to do follow-up and 82 % thought they were well located to provide psychosocial support. 53 % thought that patients would prefer to see a PCP for routine follow-up and 33 % thought it would be less stressful to patients. The 'most preferred' follow-up system was routine follow-up by PCPs with referral to hospital-based clinics if issues arise (69 %). 56 % of PCPs agreed they should be included earlier in breast cancer care following active treatment, 58 % believed they require more training and 26 % felt they receive adequately compensation to assume this role. 70 % agreed that communication between PCPs and hospitals is effective.
(continued on next page) 52 % of PCPs were very/comfortable assuming responsibility of recurrence surveillance and 43 % are very/confident they are following standard guidelines. Ambiguity about the nature, frequency and extent of surveillance testing was expressed by the majority of PCPs. PCPs suggested a desire for increased communication with oncologists; for example, specific surveillance plans, and that the transfer of care should be formalised.
(continued on next page) PCPs struggled with the defining of complimentary therapies and expressed that there was more to medicine then the physical body. Many PCPs agreed on the importance of scientific evidence, some questioned the value of evidence-based medicine as it conflicted with treating the whole patient, especially beliefs and spirituality. PCPs attitudes towards complimentary therapies ranged from complete lack of support to actively offering them to patients. PCPs recognised that their lack of knowledge could affect doctor-patient communication.
PCPs identified support, education and protection from harm as their role with complimentary therapies. Paradiso 62 Italy 263 66 % Questionnaire sent to PCPs, regional specialists and patients, regarding breast cancer follow-up.
In 85 % of cases, patients were generally followed-up by two or more specialists. 93 % of PCPs reported to prefer a more active role in the management of followup of patients. 78 % agreed that they usually do not receive any information on the goals and procedures of follow-up as dictated by the specialist. Potosky 63 United States 1072 * Cross-sectional questionnaire survey of a nationally representative sample of PCPs and medical oncologists.
38 % of PCPs preferred shared care, 25 % preferred oncologist-led and 10 % preferred PCP-led. 59 % (breast cancer) and 58 % (colon cancer) felt that PCPs have the required skills to preform follow-up care; 75 % (breast cancer) and 74 % (colon cancer) felt PCPs have the required skills to initiate screening and diagnostic tasks to detect cancer reoccurrence; and 51 % (breast and colon cancer) felt that PCPs are better able to provide psychosocial support in comparison to oncologists. Roorda 64 The Netherlands 502 53 % Cross-sectional survey of PCPs located in the three northern providences of the Netherlands.
During follow-up, PCPs reported enquiring about patient symptoms (74 %), carrying out clinical breast exams (73 %) and requesting mammograms (63 %). 80 % of PCPs felt their current contribution to follow-up was 'just right'. 40 % were willing to accept exclusive responsibility 5 years from completion of treatment and 19 % immediately or 1-2 years after. The major barriers to assuming responsibility at an earlier stage were: patient preference for specialist-led care (65 %), personal knowledge and skills (52 %) and workload pressure (36 %). Compared to specialists, 61 % felt they were better at providing psychological support. A patient-specific letter with a follow-up focus from specialists was considered the most useful tool in the transfer of care. Sada 65 United States 6 † Qualitative interview-based study of PCPs.
PCPs felt electronic health records (EHR) improved communication and efficiencyaccessibility, limiting the need to contact oncologists for basic information. Difficulties were identified in communicating with physicians outside of hospitals. PCPs still valued direct communication with oncologists e.g. via phone or email, for specific urgent problems. PCPs acknowledged that their role in cancer care diminishes during the treatment phase, particularly for comorbid conditions, discussed the need to assume a more assertive role and identified additional roles they could fill during active treatment (support for psychological distress and maintenance of healthy behaviour modification and goal setting).
(continued on next page) a need for more information from oncologists, such as through survivorship care plans (SCP), 57 enabling them to provide ongoing care. 69 For the management of paediatric cancer survivors, one study reported that 30-40 % of PCPs had participated in a conversation with a colleague about survivorship care, participated in medical education activities, or read one or more survivorship articles, and approximately 20 % had experienced formal training, possibly as distant as during their undergraduate studies. 59 lack of time and workload pressure, 49, 52, 64, 71, 72 lack of remuneration and inadequate funding, 49, 52, 72 lack of patient trust, 44, 64 inadequate resources including cancer-specific guidelines and opportunities for mental health or multi-disciplinary referrals 40, 47, 52, 60, 69 and increased medicolegal risk. 72 Qualitative and quantitative results are summarized in Table 3 .
DISCUSSION
Summary of Evidence
This review identified 35 studies representing 10,941 primary care physicians' (PCPs') perspectives of their role in caring for cancer patients and survivors. The review findings support a model of shared-care, encompassing collaboration between oncologists and PCPs that is fostered throughout the cancer trajectory, not just after the completion of active treatment. It also suggests that shared care should continue into the early survivorship period for adults, and in a possibly ongoing manner for paediatric cancers. Shared care can be fostered through the use of well-designed information transfer.
In order to meet the needs of cancer patients and survivors, various models of care have been proposed including shared care, parallel care and sequential care. 39 However, conclusive evidence has not yet determined which model may be most effective. PCPs have indicated an interest in increasing their role in cancer patient care 39, 42, 46 ; however, PCPs' limited confidence 38, 40, 54, 60, 61 and ability 40, 49, 52, 59, 64, 66, 71 to perform the various roles pose a challenge. It appears that PCP confidence levels fluctuate along the cancer care continuum and according to the type of care needed. High confidence was reported for non-cancer specific tasks such as pain management and psychosocial support, 50, 55, 63 while confidence was lower for active treatment, surveillance testing and management of long-term effects, 38, 40, 54, 60 suggesting PCPs are willing but feel unprepared to manage certain aspects of cancerspecific care. This may be attributed to PCPs' reports of minimal formal training in survivorship care, the lack of appropriate guidelines, insufficient contact with oncologists and insufficient experience. 30, 38, 40, 50, 59, 69 Improving PCP confidence to deliver cancer care is critical before a model of shared care is recommended.
Other barriers, such as poor remuneration for cancer-related services and lack of protected time and resources to upskill, may need to be further considered to support models of shared care. Few captured studies referred to the amount of support PCPs had or had not received to increase their knowledge of cancer care. 55, 59 It has been suggested systematic communication pathways, specific information, shared electronic patient records, direct contact with oncologists, clearly defined roles and adequate remuneration are needed. 38, 40, 44, 48, 51, 52, [56] [57] [58] [59] [60] 65, 69, 70 Cancer is not the major focus of PCPs' work and for timeand resource-poor PCPs; greater effort is often diverted into other more common chronic diseases. 73 The literature suggests that PCPs valued regular and detailed systems of information sharing 52 such as patient-specific guidelines 40, 44, 59, 69 or surveillance/care plans relating to their particular patient 40, 56, 57, 60, 69 rather than generalised training. With over 200 different cancer diagnoses, varying patient responses to treatment and continued advances within the medical field, cancer care is both complex and highly individualised. Thus, generalised information and training quickly becomes outdated and is less useful within this context. Therefore, the challenge of sufficiently informing PCPs appears to be closely • Lack of skill and specialist knowledge identified as barrier 52, 66 • Inability to remain informed on developments in oncology identified as barrier 66 Time and workload pressure
• Increased workload pressure/limited time if involvement was to be increased identified by 36-87 % of PCPs 49, 64, 72 • Limited time for discussing emotions identified by 38 % of PCPs
71
• Lack of time identified as barrier 52 Remuneration or funding
• Insufficient budget or increased cost identified by 79-83 % of PCPs 49, 72 • Poor remuneration identified as barrier 52 Patient trust • Patient preference or expectation for specialist-led care identified by 65-72 % of PCPs 44, 64 Resources including guidelines linked to developing resources that are patient-specific, easily accessed and current, and are able to be continually updated as care needs change. Patient-specific guidelines with the integration of a 'look-up' electronic general education resource could prove useful to overcoming knowledge and time-based barriers, 29 and would likely increase PCPs' confidence in caring for cancer patients and survivors.
Cancer care within the United States (US) remains a particular challenge as international trends of workforce shortages in oncology combined with growth of patient populations are felt. 17 Despite PCPs' interest in an increased role in aspects of cancer care, the trajectory of care is often fragmented among various specialities. 74 The findings of this review are especially useful for generalists in the US-where one-third of included studies originate-providing a summary of evidence to begin discussion surrounding altering the existing model of care taking into account the preferences of PCPs and the unique features of the US healthcare system.
Finally, childhood cancer survivors pose a unique challenge for PCPs in cancer care. There is a dearth of literature directly addressing the PCP's role as related to caring for this specific group. 53, 59 As paediatric cancer survivors are rarely encountered by PCPs, building this area of specialty in the general practice setting remains an exciting field of research to be further investigated.
Study Limitations
This review included only studies exploring the PCPs' perspective of their role within cancer care. However, it is essential that any changes to the current model of care should also be congruent with the preferences of oncologists and patients. Of the 35 included studies, in addition to investigating PCP preferences, 11 of the studies also explored the views of oncologists and/or patients (see 39, 42, 46, 49, 50, 56, 57, 62, 63, 65, 72 for recent studies of patient and oncologist preferences); however, these results were not reported as part of this review. The search strategy also excluded intervention studies; however, these may objectively provide information regarding viable models of care, beyond PCPs' personal preferences. Additionally, as studies originated from 11 countries, each with different models of health care, payment systems and doctor-patient ratios, this limits the potential for dissemination of information on an international level.
CONCLUSIONS
In light of PCPs' perspectives and preferences, the feasibility of increasing the role of PCPs in cancer care remains unknown. However, given adequate support, PCPs are willing to increase their role in cancer care, with potential medical and economic benefits for patients, oncologists and the health care system.
